Two doses of psilocybin, the active ingredient in “magic mushrooms,” against a six-week course of the popular antidepressant ...

Schizoaffective disorder is a chronic mental health condition characterized by symptoms of both schizophrenia and mood ...

People with psychiatric conditions are more likely to be hospitalized or die of the virus. Scientists have ideas about why ...

RTI International launched a randomized, controlled trial of SGB in 2014 and concluded in 2019 that the treatment "is indeed ...

Although most research and attention focus on adults, children and adolescents suffer from chronic pain and mental health ...